Earnings Alerts

China Vanke (H) (2202) Earnings: September Contracted Sales Reach 17.42B Yuan

By October 11, 2024 No Comments
  • In September 2024, China Vanke reported contracted sales amounting to 17.42 billion yuan.
  • The year-to-date contracted sales up to September 2024 reached 181.2 billion yuan.
  • Analysts’ recommendations for China Vanke stock include 6 buy ratings, 10 hold ratings, and 3 sell ratings.

A look at China Vanke (H) Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth3
Resilience2
Momentum5
OVERALL SMART SCORE4.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Vanke (H) is showing strength in its value and dividend factors, scoring the highest possible scores of 5 in both areas. This indicates a solid financial foundation and a commitment to rewarding shareholders. However, in terms of growth, resilience, and momentum, the company scores slightly lower, with scores of 3, 2, and 5 respectively. Despite these mixed scores, China Vanke (H) remains a prominent property development company with a strong presence in major Chinese cities like Shenzhen, Shanghai, and Beijing.

Overall, the Smartkarma Smart Scores paint a positive picture for China Vanke (H) in the long term. While the company excels in value and dividend factors, it may need to focus on improving its growth and resilience aspects to ensure sustained success in a competitive market. With a solid momentum score indicating positive market sentiment, China Vanke (H) remains a key player in the property development sector in China, especially in major metropolitan areas.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars